Company / Operating Margin
Aquestive Therapeutics, Inc. Operating Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-159.5%
FY2025
5-year range
-159.5% / -29.9%
FY2021-FY2025
Trend
-198.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -29.9% to -159.5% over the past 2 years.
Based on SEC 10-K filings.
-159.5% in FY2025 with a 5-year CAGR of -59.4%.
Declined from -29.9% to -159.5% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -71.3pp
- 5-Year Change
- -59.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin decreased 198.4% year-over-year.
- Peak operating margin was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -159.5% | -198.4% |
| FY2024 | -53.5% | -79.0% |
| FY2023 | -29.9% | +66.2% |
| FY2022 | -88.2% | +5.7% |
| FY2021 | -93.5% | +6.6% |
| FY2020 | -100.1% | -37.9% |
| FY2019 | -72.6% | -42588.2% |
| FY2018 | -0.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026